Pricing

We are committed to making live tumor storage accessible to as many individuals and their loved ones as possible. By working with leading industry experts in our field, we have developed a unique process for collecting and storing live tissue that has been validated and quality tested.

Pricing Includes…

  • Legal documentation to gain control of your tissue
  • Tissue shipping/handling fees to the laboratory
  • Report from board-certified pathologist about the volume of stored tissue that was harvested and successfully preserved and ready for use
  • Patient Advocate Support Services
  • Collection kit (SpeciKit)
  • Tissue processing & analysis
  • Tissue cryopreservation fees
  • Ongoing management/maintenance fees

DISCLAIMER: This cost covers consultations with SpeciCare patient advocates and experts who help educate, guide and direct living tumor usage by the patient and their referring physician. Additional retrieval, administrative and shipping fees will apply according to directed use of living tumor tissue. SpeciCare does not make medical decisions on behalf of the patient, but provides options and new avenues to consider with their clinical care team. The patient owns and controls usage of their living tissue with the help of their personal clinical care team.

HIGH QUALITY. ACCESSIBLE PRICE.

Our unique process developed with SpeciCare takes living tissue from the patient to preserve in several formats, thereby maximizing opportunities for the specimens use for the patient’s benefit. This biological material is preserved using state-of-the art cryopreservation methods similar to those used by industry-leading biorepositories and in vitro fertilization clinics worldwide. All specimens are reviewed by ASCP-certified cytotechnologists and board certified pathologists in order to determine the content and quality of preserved specimens.

We are pleased with the process that has been developed because it empowers the patient to take part in their own outcomes. By preserving cells and tissue from the patient and giving them ownership of the specimens, they become an active participant in the treatment process. We are very excited to be able to provide this service to the patient through our work with SpeciCare and hope that by increasing the availability of high-quality specimens, cancer treatment can evolve to a more informed and targeted process at the individual level.

DR. CAROL C. EISENHUT MD, MBA

President, DCL Pathology
SpeciCare Partner

CALL US Save your Tumor today
Top of Page